Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TDX ETHOSUXIMIDE

K-Number: K850174 · 1985-02-06

ApplicantAbbott Laboratories
Decision Date1985-02-06
Product CodeDLF
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

TDX ETHOSUXIMIDE is the device name listed in this FDA 510(k) record. The listed applicant is Abbott Laboratories. It received FDA 510(k) clearance on 1985-02-06 under 510(k) number K850174. The device is classified under product code DLF. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TDX ETHOSUXIMIDE?

TDX ETHOSUXIMIDE is a medical device that received FDA 510(k) clearance on 1985-02-06. The listed applicant is Abbott Laboratories. The 510(k) number is K850174.

When did TDX ETHOSUXIMIDE receive FDA 510(k) clearance?

TDX ETHOSUXIMIDE received FDA 510(k) clearance on 1985-02-06, under 510(k) number K850174.

Who is the listed applicant for TDX ETHOSUXIMIDE?

The FDA 510(k) record lists Abbott Laboratories as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for TDX ETHOSUXIMIDE?

The FDA product code for TDX ETHOSUXIMIDE is DLF.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Abbott Laboratories as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K262156Anti-HCV NextK252424Anti-HCV NextK243500ARCHITECT iGentamicinK243168Alinity i Rubella IgGK243283Alinity h-series SystemK233932Alinity i Toxo IgM

View all 876 devices →

Related Devices (Code: DLF)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K881607EASY-TEST EMIT(R) ETHOSUXIMIDE (ETHS) ITEM 16647Em Diagnostic Systems, Inc.K844204EMIT QST ETHOSUXIMIDE ASSAYSyva Co.K832797MODIFICA- OF EMIT AED ETHOSUXIMIDE ASSAYSyva Co.K823801AMES TDA ETHOSUXIMIDE TESTMiles Laboratories, Inc.K823745ADVANCE EMIT-AED ETHOSUXIMIDESyva Co.K792584ACA ETHOSURIMIDE TEST PACKE.I. Dupont DE Nemours & Co., Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑